Global Biological Drugs Market is Expected to Reach USD 287,139.7 Million in 2020

The global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 287,139.7 million in 2020.

Browse the full Biological Drugs Market Report at http://www.transparencymarketresearch.com/biological-drugs-market.html

The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.

On the other hand, high cost of biological drugs and patent expiry of blockbuster drugs impede the growth of the market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020.

Browse Press Release of Biological Drugs Market @ http://www.transparencymarketresearch.com/pressrelease/biological-drugs-market.htm

North America is the largest market for biological drugs. Increased use of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. The American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S.

Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases.

In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities.

Request for customization of this report http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1694

Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are the some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc.

The global market of biological drugs is segmented as follows:

Browse all Press Releases: http://www.transparencymarketresearch.com/press-releases.htm

Biological Drugs Market, By Therapeutic Protein

Enbrel

Lantus

Neulasta

Avonex

NovoLog

Rebif

Humalog

Aranesp

Epogen

Levemir

Victoza

Betaseron

Neupogen

Eylea

Browse all Article : http://www.transparencymarketresearch.com/articles.htm

Biological Drugs Market, By Monoclonal Antibody (mAb)

Humira

Remicade

Rituxan

Avastin

Herceptin

Lucentis

Biological Drugs Market, By Vaccine

Prenvar 13

Gardasil

Fluzone

Varivax

Cervarix

Biological Drugs Market, by Geography

North America

Europe

Asia

Rest of the World (RoW)

Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html